Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/319898
Full metadata record
DC FieldValueLanguage
dc.contributor.CRUESPUNIVERSIDADE DE ESTADUAL DE CAMPINASpt_BR
dc.identifier.isbn1573-2630pt
dc.typeArtigo de Periódicopt_BR
dc.titleIntraocular Pressure Control After The Implantation Of A Second Ahmed Glaucoma Valvept_BR
dc.contributor.authorJimenez-Romanpt_BR
dc.contributor.authorJ; Gil-Carrascopt_BR
dc.contributor.authorF; Costapt_BR
dc.contributor.authorVP; Schimitipt_BR
dc.contributor.authorRB; Lernerpt_BR
dc.contributor.authorF; Santanapt_BR
dc.contributor.authorPR; Vascocellospt_BR
dc.contributor.authorJPC; Castillejos-Chevezpt_BR
dc.contributor.authorA; Turatipt_BR
dc.contributor.authorM; Fabre-Mirandapt_BR
dc.contributor.authorKpt_BR
unicamp.author.emaila.castillejos@me.compt_BR
dc.subjectGlaucoma Drainage Devicept_BR
dc.subjectAhmed Drainage Devicept_BR
dc.subjectGlaucomapt_BR
dc.subjectSurgerypt_BR
dc.description.abstractThe objective of this study is to evaluate the efficacy and safety of a second Ahmed glaucoma valve (AGV) in eyes with refractory glaucoma that had undergone prior Ahmed device implantation. This multicenter, retrospective study evaluated 58 eyes (58 patients) that underwent a second AGV (model S2-n = 50, model FP7-n = 8) due to uncontrolled IOP under maximal medical therapy. Outcome measures included IOP, visual acuity, number of glaucoma medications, and postoperative complications. Success was defined as IOP < 21 mmHg (criterion 1) or 30 % reduction of IOP (criterion 2) with or without hypotensive medications. Persistent hypotony (IOP < 5 mmHg after 3 months of follow-up), loss of light perception, and reintervention for IOP control were defined as failure. Mean preoperative IOP and mean IOPs at 12 and 30 months were 27.55 +/- A 1.16 mmHg (n = 58), 14.45 +/- A 0.83 mmHg (n = 42), and 14.81 +/- A 0.87 mmHg (n = 16), respectively. The mean numbers of glaucoma medications preoperatively at 12 and 30 months were 3.17 +/- A 0.16 (n = 58), 1.81 +/- A 0.2 (n = 42), and 1.83 +/- A 0.35 (n = 18), respectively. The reductions in mean IOP and number of medications were statistically significant at all time intervals (P < 0.001). According to criterion 1, Kaplan-Meier survival curves disclosed success rates of 62.9 % at 12 months and 56.6 % at 30 months. According to criterion 2, Kaplan-Meier survival curves disclosed success rates of 43.9 % at 12 months and 32.9 % at 30 months. The most frequent early complication was hypertensive phase (10.3 %) and the most frequent late complication was corneal edema (17.2 %). Second AGV implantation may effectively reduce IOP in eyes with uncontrolled glaucoma, and is associated with relatively few complications.en
dc.relation.ispartofInternational Ophthalmologypt_BR
dc.publisher.cityDORDRECHTpt_BR
dc.publisherSPRINGERpt_BR
dc.date.issued2016pt_BR
dc.identifier.citationInternational Ophthalmology. SPRINGER, n. 36, n. 3, p. 347 - 353.pt_BR
dc.language.isoEnglishpt_BR
dc.description.volume36pt_BR
dc.description.issuenumberpt_BR
dc.description.firstpage347pt_BR
dc.description.lastpage353pt_BR
dc.rightsfechadopt_BR
dc.sourceWOSpt_BR
dc.identifier.issn1573-2630pt_BR
dc.identifier.wosidWOS:000376262200008pt_BR
dc.identifier.doi10.1007/s10792-015-0125-zpt_BR
dc.identifier.urlhttp://link.springer.com/article/10.1007%2Fs10792-015-0125-zpt_BR
dc.date.available2016-12-06T18:29:54Z-
dc.date.accessioned2016-12-06T18:29:54Z-
dc.description.provenanceMade available in DSpace on 2016-12-06T18:29:54Z (GMT). No. of bitstreams: 1 000376262200008.pdf: 380264 bytes, checksum: 5d1df1d3d3fdb745947f791c7a3cd32d (MD5) Previous issue date: 2016en
dc.identifier.urihttp://repositorio.unicamp.br/jspui/handle/REPOSIP/319898-
dc.description.conferencelocationpt_BR
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
000376262200008.pdf371.35 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.